Navigation Links
Quantel Signs a Distribution Agreement With US-based National Biological
Date:10/14/2009

LES ULIS, France, October 14 /PRNewswire-FirstCall/ --

- National Biological to Market Quantel`s 308 Excimer System for Psoriasis and Vitiligo in the United States

Quantel SA (Euronext: QUA), a leading manufacturer of solid state lasers, announced today that it has entered into a Distribution Agreement with National Biological, a leading researcher and developer of light-based systems for medical and cosmetic treatments, for Quantel's 308 Excimer System for monochromatic UVB treatment of psoriasis and vitiligo in the United States.

Monochromatic UVB Therapy

The 308 Excimer System was developed by Quantel Derma, GmbH based in Erlangen, Germany. Its monochromatic light is equivalent to an excimer laser, with comparable clinical results. The 308 Excimer System is portable, efficient and has no consumables.

National Biological's Chief Executive Officer, Ken Oif commented, "The Quantel 308 targeted phototherapy System provides the best solution for the tens of thousands of patients who require localized treatment for psoriasis, vitiligo, and other skin diseases which are responsive to UV light. It is proven to be very effective and extremely easy to use. National Biological is very pleased to be able to provide Dermatologists with the best value of any targeted phototherapy system."

Exclusivity in the United States

The 308 Excimer System will be exclusively marketed by National Biological in the United States. National Biological will provide the Marketing, Sales, Clinical and Service support.

Alain de Salaberry, Quantel's Président Directeur Général said: "Its strong sales organization and its experience with UVB devices make National Biological an ideal partner for the marketing of Quantel's 308 Excimer System."

ABOUT THE QUANTEL Group

Founded in 1970, the QUANTEL Group has over the last 10 years established itself as one of the world's leading specialists for scientific (research laboratories, universities), industrial (micromachining, metrics, military) and medical (ophthalmology, dermatology) laser technologies.

ABOUT Nation Biological Corporation, Inc.

National Biological was founded in 1967 by a pharmacist who understood clearly that UV phototherapy provided a safer and more effective treatment than drugs for severe or chronic psoriasis, eczema, vitiligo and other skin conditions. Over the nearly 40 years since then, National Biological has become widely recognized among doctors and patients alike as the world leader in our field, consistently providing innovation, manufacture, and distribution of phototherapy equipment.

    Quantel is listed on NYSE Euronext (compartiment C) FR0000038242 - QUA
    http://www.quantel-laser.com

    Alain de SALABERRY
    Président Directeur Général
    T : +33-1-69-29-17-00
    info@quantel.fr

    Stefan SCHULZE
    CEO Quantel Derma GmbH
    T : +49-9131-9408810
    info@quantel-derma.com

    Mark Friedman
    President
    T : +1-216-831-0600
    Info@PhototherapyExperts.com

SOURCE QUANTEL


'/>"/>
SOURCE QUANTEL
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 MarketNewsUpdates.com News Commentary  ... The ... are being pressured as of late due to the rise ... management has a dramatic impact on patient,s quality of life ... activities for identifying new forms of opioid formulations that prevent ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered ... for high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration ...
(Date:3/22/2017)... BALTIMORE , March 22, 2017  Personal ... of its cancer testing contract with the U.S. ... earlier tumor profiling assay with the company,s new ... a comprehensive, clinically actionable pan-cancer profiling test that ... to assess potential patient response to checkpoint inhibitor ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):